Columbia Care Inc
F:3LP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Columbia Care Inc
Cash & Cash Equivalents
Columbia Care Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Columbia Care Inc
F:3LP
|
Cash & Cash Equivalents
$48.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash & Cash Equivalents
$9.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-4%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash & Cash Equivalents
$10.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
16%
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash & Cash Equivalents
$1.1B
|
CAGR 3-Years
40%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-11%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash & Cash Equivalents
$14.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash & Cash Equivalents
$7.3B
|
CAGR 3-Years
52%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
Columbia Care Inc
Glance View
Columbia Care, Inc. engages in the cultivation, manufacture and provision of medical cannabis products and services. The company is headquartered in New York City, New York. The company went IPO on 2019-04-29. The firm is engaged cultivating, manufacturing and providing medical and adult use cannabis products and related services with licenses in over 18 the United States jurisdictions and the European Union (EU). The firm operates facilities including dispensaries and cultivation and manufacturing facilities. The firm operates as the original providers of medical cannabis in the United States and continues to deliver a patient-centered medicinal cannabis operation. The firm offers products spanning flower, edibles, oils, and tablets, and manufactures brands including Seed & Strain, Amber and Platinum Label Cannabidiol (CBD) products. The company develops products which comprised of a variety of medical and adult-use form factors, including but not limited to formulations, precision manufactured dosing and cannabis flower and flower-derived products.
See Also
What is Columbia Care Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
48.2m
USD
Based on the financial report for Dec 31, 2022, Columbia Care Inc's Cash & Cash Equivalents amounts to 48.2m USD.
What is Columbia Care Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
29%
Over the last year, the Cash & Cash Equivalents growth was -41%.
